CAI Earnings Date: Nov 4, 2026 (Estimated) — Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CAI's next earnings date?
Caris Life Sciences, Inc. (CAI) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.03 on revenue of $255.4M.
How did CAI do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Caris Life Sciences, Inc. posted EPS of $0.00 versus the $0.01 estimate, a miss of 100.0%. Revenue was $263.7M against a $238.1M estimate. The stock's 1-day post-earnings move was +21.6%.
How much does CAI stock move after earnings?
CAI beat EPS estimates in 6 of its last 7 reported quarters. Over the last 5 reports the stock moved an average of 13.2% (up or down) in the day after earnings.
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 0.01 | 0.00 | -100.00% | $263.7M | ❌ Miss | +21.58% | +35.32% | +53.92% |
| 2026-05-07 | Q1 2026 | -0.02 | 0.00 | +100.00% | $216.2M | ✅ Beat | -18.60% | -23.14% | -18.65% |
| 2026-02-26 | Q4 2025 | 0.07 | 0.28 | +300.00% | $292.9M | ✅ Beat | +4.68% | -0.10% | -11.90% |
| 2025-11-05 | Q3 2025 | -0.11 | 0.08 | +172.73% | $216.8M | ✅ Beat | -15.75% | -15.20% | -1.20% |
| 2025-08-12 | Q2 2025 | — | -7.97 | — | $181.4M | — | +5.61% | +13.77% | +5.39% |
| 2021-11-05 | 0.61 | 2.95 | — | $100.8M | ✅ Beat | — | — | — | |
| 2021-08-03 | 1.20 | 2.20 | — | $85.7M | ✅ Beat | — | — | — | |
| 2021-04-30 | 1.44 | 2.07 | — | $80.8M | ✅ Beat | — | — | — |
Showing last 8 quarters.